A lesson learnt: the rise and fall of Lariam and Halfan.
Croft
Ashley M
AM
Medical Branch, Headquarters 5th Division, Copthorne Barracks, Shrewsbury SY3 8LZ, UK. ashley.croft810@land.mod.uk
D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D004345:Drug Industry; D005380:Financing, Government; D005544:Forecasting; D006801:Humans; D007400:Interprofessional Relations; D008288:Malaria / Q000188:drug therapy*; D015767:Mefloquine / Q000009:adverse effects / Q000627:therapeutic use*; D001523:Mental Disorders / Q000139:chemically induced*; D008889:Military Personnel; D010616:Phenanthrenes / Q000009:adverse effects / Q000627:therapeutic use*; D013678:Technology, Pharmaceutical; D014481:United States; D014486:United States Food and Drug Administration
D000962:Antimalarials; D010616:Phenanthrenes; C023768:halofantrine; D015767:Mefloquine